JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2013, 62(1):28-34

Diclofenac sodium entrapment and release from halloysite nanotubules

Kateřina Krejčová1, Patrick B. Deasy1, Miloslava Rabišková2,*
1 School of Pharmacy, Trinity College Dublin, Dublin, Ireland
2 Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic

Halloysite was found to have interesting nanotubular geometry viable for the entrapment of various active agents. In this experiment, the ability of hollow halloysite cylinders to entrap the anionic model drug diclofenac sodium and to retard drug dissolution rate was investigated. Drugs could be incorporated into layered tubules via three different mechanisms: adsorption, intercalation and tubular entrapment. Based on the adsorption studies, some diclofenac sodium was shown to be adsorbed to the polyionic mineral surface despite its permanent negative charge. The X-ray powder diffraction analysis (XRPD) results did not prove any intercalation reaction to occur. The most important drug-loading mechanism involved the tubular entrapment with encapsulation efficiency 48.1%. The drug release from halloysite was prolonged in comparison with the dissolution of pure drug. Halloysite itself as well as halloysite loaded with the drug proved to be appropriate material to form pellets by extrusion /spheronization method.

Keywords: halloysite; diclofenac sodium; drug entrapment; pellets; prolonged drug release

Received: December 12, 2012; Accepted: January 16, 2013; Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejčová K, Deasy PB, Rabišková M. Diclofenac sodium entrapment and release from halloysite nanotubules. Čes. slov. farm. 2013;62(1):28-34.
Download citation

References

  1. Christie T., Fletcher W. K. Contamination from forestry activities: implications for stream sediment exploration programmes. J. Geo. Exp. 1999; 67, 201-210. Go to original source...
  2. Price R. R., Gaber B. P., Lvov Y. M. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite. J. Microencapsulation 2001; 18, 713-722. Go to original source... Go to PubMed...
  3. Rabišková M. Halloysite - interesting nanotubular carrier for drugs - review. Čes. a slov. Farm. 2012; 61, 255-260.
  4. Carr R. M. Chih H. Complexes of halloysite with organic compounds. Clay Miner 1971; 9, 153-166. Go to original source...
  5. Harrison J. L., Greenburg S. S. Dehydration of fully hydrated halloysite from Lawrence county Indiana. Clay Miner. 1962; 9, 374-377. Go to original source...
  6. Wada K. Lattice expansion of kaolinite minerals by treatment with potassium acetate. Am. Miner. 1961; 46, 78-91.
  7. Levis S. R., Deasy P. B. Characterization of halloysite for use as a microtubular drug delivery system. Int. J. Pharm. 2002; 243, 125-134. Go to original source... Go to PubMed...
  8. Lvov Y. M., Price R., Gaber B., Ichinose I. Thin film nanofabrication via layer-by-layer adsorption of tubule halloysite, spherical silica, proteins and polycations. Colloids and Surfaces A: Physicochem. Eng. Aspects 2002; 198-200, 375-382. Go to original source...
  9. Levis S. R., Deasy P. B. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int. J. Pharm. 2003; 253, 145-157. Go to original source... Go to PubMed...
  10. Kelly H. M., Deasy P. B., Ziaka E., Claffey N. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int. J. Pharm. 2004; 274, 167-183. Go to original source... Go to PubMed...
  11. Zambito Y., Di Colo G. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J. Pharm. Pharm. Sci. 2003; 6, 274-281.
  12. Kloprogge J. T., Frost R. L. Raman microprobe spectroscopy of hydrated halloysite from a neogene cryptoclast from southern Belgium. J. Raman Spectroscopy 1999; 30, 1079-1085. Go to original source...
  13. Lee S. Y., Kim S. J. Adsorption of naphthalene by HDTMA modified kaolinite and halloysite. Appl. Clay Sci. 2002; 22, 55-63. Go to original source...
  14. Frost R. L., Tran T. H., Kristof J. FT-Raman spectroscopy of the lattice region of kaolinite and its intercalates. Vibrational Spectroscopy 1997; 13, 175-186. Go to original source...
  15. Tari G., Bobos I., Gomes C. S. F., Ferreira J. M. F. Modification of surface charge properties during kaolinite to halloysite-7Å transformation. J. Colloid Interface Sci. 1999; 210, 360-366. Go to original source... Go to PubMed...
  16. Lee G., Rupprecht H. Adsorption at solid surfaces. In: Swarbrick J., Boylan J.C., editors. Encyclopedia of Pharmaceutical Technology. 1st ed. New York - Basel: Marcel Dekker, Inc. 1998, 73-114.
  17. Suh Y. J., Kil D. S., Chung K. S., Abdullayev E., Lvov Y. M., Montagyt D. Natural nanocontainer for the controlled delivery of glycerol as moisturizing agent. J. Nanoscience Nanotechnology 2001; 11, 661-665. Go to original source... Go to PubMed...
  18. Christie T., Thompson B., Brathwaite B. Mineral Commodity Report 20 - Clays. New Zealand Mining 2000; 27, 26-43.
  19. Kincl M., Vrečer F., Veber M. Characterization of factors affecting the release of low-solubility drug from prolonged release tablets. Anal. Chim. Acta 2004; 502, 107-113. Go to original source...
  20. Fini A., Fazio G., Gonzales-Rodriguez M., Cavallari C., Passerini N., Rodriguez L. Formation of ion-pairs in aqueous solutions of diclofenac sodium. Int. J. Pharm. 1999; 187, 163-173. Go to original source... Go to PubMed...
  21. Podczeck F., Rahman S. R., Newton J. M. Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int. J. Pharm. 1999; 192, 123-138. Go to original source... Go to PubMed...
  22. Deasy P. B., Law M. F. L. Use of extrusion-spheronization to develop an improved oral dosage form of indomethacin. Int. J. Pharm. 1997; 148, 201-209. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.